Valued at a market cap of $8.5 billion, Henry Schein, Inc. (HSIC) is a premier global provider of healthcare solutions, ...

Shares of Henry Schein Inc. HSIC slid 1.12% to $68.62 Friday, on what proved to be an all-around dismal trading session for ...

Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Henry Schein in a research note issued to ...

Shield Healthcare does seem to be a clear outlier, with an EV to sales multiple of 1.9. But the others seem to range between 4.2 and 6.3. To put this in perspective, Henry Schein it's trading at ...

Henry Schein is part of the Zacks Medical - Dental ... representing a year-over-year change of +2.3%. EPS of $1.82 for the same period compares with $1.83 a year ago. West Pharmaceutical is ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq ... We continued to make progress on our 2022 to 2024 BOLD+1 Strategic Plan which we recently completed, exceeding our 2024 target ...

Selection of comprehensive health care solutions to help dental professionals operate successfully and deliver high-quality patient care At Henry Schein’s exhibition booth in Hall 4.1 ...

On Feb. 25, Henry Schein reported its fourth-quarter results ... Non-GAAP EPS came in at $1.19, aligning with estimates, while operating margin improved, supported by restructuring efforts.

Shares of Henry Schein Inc. HSIC slipped 1.61% to $70.84 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.08% to 5,675.29 ...